Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Dihydroartemisinin + Piperaquine
- Therapeutic area
- Anti-infectives
- Drug class
- Antimalarials
- ATC
- P01BF
- Strength
- 40 mg + 320 mg
- Dosage form
- Capsule
- Pack
- 8'S
- Registration no.
- 055908
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-15 03:06
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What ARTEQUINE (Dihydroartemisinin + piperaquine) is used for
Dihydroartemisinin and piperaquine are two antimalarial medicines combined in one tablet. Dihydroartemisinin (an artemisinin medicine) acts fast to clear malaria parasites from the blood. Piperaquine acts for longer, to clear the parasites that are left and to help protect against catching malaria again for a while. Using two medicines together also lowers the chance that the parasites become resistant. It is a prescription medicine, and the World Health Organization (WHO) has approved (prequalified) versions of this tablet.
- Uncomplicated malaria (malaria that has not become severe), especially malaria caused by the falciparum parasite
- The WHO product information says it works against all the malaria parasites that infect people, while the European physician guide lists it for falciparum malaria only and not for vivax, malariae or ovale. A doctor decides which one applies to you.
- It can be used in adults, children and infants, as set out in the product information
Get medical help straight away if
- Get urgent medical help for a fast, pounding or uneven heartbeat, or any serious heart rhythm problem. This medicine can lengthen the QT interval of the heartbeat, which can very rarely lead to dangerous rhythm problems.
- Get urgent help if a child has a fit (convulsion).
- Get urgent help for signs of a severe allergic reaction, such as swelling of the face, lips, tongue or throat, or trouble breathing.
- See a doctor quickly if you become very pale, tired or breathless, or your skin or eyes turn yellow. Anaemia caused by red blood cells breaking down has been reported some time after treatment, and jaundice needs checking.
Side effects, warnings and interactions for Dihydroartemisinin + piperaquine
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Dihydroartemisinin + Piperaquine
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Dihydroartemisinin + Piperaquine is right for you and the dose.
- Malaria: first-choice treatment for uncomplicated falciparum malaria
About ARTEQUINE 40 mg + 320 mg capsule
ARTEQUINE 40 mg + 320 mg capsule contains Dihydroartemisinin + Piperaquine 40 mg + 320 mg. It is registered with DRAP by Platinum Pharmaceuticals (registration no. 055908). Its official price is PKR 821.62 for a pack of 8'S, about PKR 102.70 per capsule. This price has applied since 23 July 2026. ARTEQUINE is also available as 15 mg + 120 mg sachet, 15 mg + 120 mg/sachet sachet and 40 mg + 320 mg tablet. 7 other brands of Dihydroartemisinin + Piperaquine 40 mg + 320 mg (capsule) are registered in Pakistan. Compare all brands and prices →
Other strengths of ARTEQUINE
All 7 other brands of Dihydroartemisinin + Piperaquine 40 mg + 320 mg capsule in Pakistan
These 7 brands are alternatives (substitutes) to ARTEQUINE: each contains Dihydroartemisinin + Piperaquine 40 mg + 320 mg capsule. Ask your doctor or pharmacist before you switch brands.
Sorted by price per capsule, lowest first. The lowest is Artepip 40/320 (Helix Pharma (Pvt)., Ltd) at PKR 77.66 per capsule; the highest is TIMEQUIN at PKR 103. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Artepip 40/320 | Helix Pharma (Pvt)., Ltd | 8's | PKR 621.28 | PKR 77.66 / capsule |
| EUARIA | Martin Dow Limited | 8's | PKR 690.50 | PKR 86.31 / capsule |
| Temquin | Searle IV Solutions (Pvt) Ltd | 8’s | PKR 698.40 | PKR 87.30 / capsule |
| Piquin | Nabiqasim Industries (Pvt) Ltd | 8's | PKR 758.00 | PKR 94.75 / capsule |
| Paraquin | Genome Pharmaceuticals (Pvt.) Ltd | 1 x 8's | PKR 782.73 | PKR 97.84 / capsule |
| DIPAVIN (DIPIP) | Hilton Pharma (Pvt) Limited | 8's | PKR 798.66 | PKR 99.83 / capsule |
| TIMEQUIN | SAMI Pharmaceuticals Pvt. Ltd | 8's | PKR 821.63 | PKR 103 / capsule |
See every strength and form of Dihydroartemisinin + Piperaquine →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for ARTEQUINE, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Platinum Pharmaceuticals, Karachi
- DRAP registration
- 055908
- Phone
- +92 21 34750112-3
- info@platinumpharma.net
- Website
- https://platinumpharma.net/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (8'S). Current price PKR 821.62, effective 23 Jul 2026.
Cite this price history
MedInfoBase. ARTEQUINE 40 mg + 320 mg, 8'S: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/artequine-40-mg-055908-8s-platinum-pharmaceuticals/ (accessed 15 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 821.62 | 2026-07-23 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 055908Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.